Characteristics associated with differences in survival among black and white women with breast cancer

JAMA

Volumn 310, Issue 4, 2013, Pages 389-397

  Silber, Jeffrey H ^a,b,c,d,e   Rosenbaum, Paul R ^d,e   Clark, Amy S ^b,c,f   Giantonio, Bruce J ^b,c,f   Ross, Richard N ^a   Teng, Yun ^a   Wang, Min ^a   Niknam, Bijan A ^a   Ludwig, Justin M ^a   Wang, Wei ^a   Even Shoshan, Orit ^a,e   Fox, Kevin R ^b,c,f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; PACLITAXEL; TAXANE DERIVATIVE;

AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 84880431535     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.8272     Document Type: Article

References (58)

1. Haas JS, Earle CC, Orav JE, et al. Racial segregation and disparities in breast cancer care and mortality. Cancer. 2008;113(8):2166-2172.
2. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93. (Pubitemid 38519418)
3. Gorey KM, Luginaah IN, Schwartz KL, et al. Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001. Breast Cancer Res Treat. 2009;113(3):595-600.
4. Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS. Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med. 2006;62(2):337-347. (Pubitemid 41735422)
5. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer. 2008;112(1):171-180.
6. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127(3):729-738.
7. Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002;95(9):1988-1999. (Pubitemid 35222180)
8. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541-553. (Pubitemid 46768143)
9. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128(9):729-736. (Pubitemid 28204864)
10. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765-1772. (Pubitemid 41434622)
11. Chagpar AB, Crutcher CR, Cornwell LB, McMasters KM. Primary tumor size, not race, determines outcomes in women with hormone-responsive breast cancer. Surgery. 2011;150(4):796-801.
12. McBride R, Hershman D, Tsai WY, Jacobson JS, Grann V, Neugut AI. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer. Cancer. 2007;110(6):1201-1208. (Pubitemid 47435589)
13. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639-6646. (Pubitemid 46190258)
14. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(20):2244-2252. (Pubitemid 44748771)
15. Byers TE, Wolf HJ, Bauer KR, et al Patterns of Care Study Group. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008;113(3):582-591.
16. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8)(suppl):IV-3-IV-18.
17. SEER-Medicare Linked Database. National Cancer Institute website. http://healthservices.cancer.gov/seermedicare. Accessed August 8, 2012.
18. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8)(suppl):IV-19-IV-25.
19. Silber JH, Rosenbaum PR, Kelz RR, et al. Medical and financial risks associated with surgery in the elderly obese. Ann Surg. 2012;256(1):79-86.
20. Silber JH, Rosenbaum PR, Trudeau ME, et al. Multivariate matching and bias reduction in the surgical outcomes study. Med Care. 2001;39(10):1048-1064. (Pubitemid 33691380)
21. Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among hospitalized Medicare beneficiaries in the first 2 years following ACGME resident duty hour reform. JAMA. 2007;298(9):975-983. (Pubitemid 47360808)
22. Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among patients in VA hospitals in the first 2 years following ACGME resident duty hour reform. JAMA. 2007;298(9):984-992. (Pubitemid 47360809)
23. Rubin DB. For objective causal inference, design trumps analysis. Ann Appl Stat. 2008;2(3):808-840.
24. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26(1):20-36. (Pubitemid 46099415)
25. Rubin DB. Using propensity scores to help design obserational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3-4):169-188.
26. SAS Institute Inc. SAS/OR User's Guide: Mathematical Programming (Version 8). Cary, NC: SAS Institute Inc; 1999:39-54.
27. Rosenbaum PR. Design of Observational Studies. New York, NY: Springer; 2010.
28. Rosenbaum PR, Ross RN, Silber JH. Minimum distance matched sampling with fine balance in an observational study of treatment for ovarian cancer. J Am Stat Assoc. 2007;102(477):75-83.
29. Yang D, Small DS, Silber JH, Rosenbaum PR. Optimal matching with minimal deviation from fine balance in a study of obesity and surgical outcomes. Biometrics. 2012;68(2):628-636.
30. Rosenbaum PR. Design of Observational Studies. New York, NY: Springer; 2010:197-206.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
32. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
33. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590. (Pubitemid 47096709)
34. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267. (Pubitemid 32007842)
35. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
36. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150(4):327-333. (Pubitemid 29383480)
37. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1):33-38.
38. Cochran WG, Rubin DB. Controlling bias in observational studies: a review. Sankhyā. 1973;35:417-446.
39. Heller R, Rosenbaum PR, Small D. Using the cross-match test to appraise covariate balance in matched pairs. Am Stat. 2010;64(4):299-309.
40. Hollander M, Wolfe DA. Nonparametric Statistical Methods. 2nd ed. New York, NY: John Wiley & Sons; 1999.
41. Bishop YMM, Fienberg SE, Holland PW. Discrete Multivariate Analysis: Theory and Practice. Cambridge: MIT Press; 1975:281-286.
42. Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley; 1980.
43. O'Brien PC, Fleming TR. A paired Prentice-Wilcoxon test for censored paired data. Biometrics. 1987;43(1):169-180. (Pubitemid 17063900)
44. Holt J, Prentice R. Survival analysis in twin studies and matched pair experiments. Biometrika. 1974;61(1):17-30.
45. Efron B, Tibshirani R. Bootstrapmethods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1(1):54-75.
46. Rosenbaum PR, Silber JH. Using the exterior match to compare two entwined matched control groups. Am Stat. 2013;67(2):67-75.
47. Statistical Analytic Software System for UNIX (Version 9.2). Cary, NC: SAS Institute Inc; 2009.
48. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing website. www.R-project.org. 2012. Accessed May 14, 2013.
49. Rosenbaum PR. An exact distribution-free test comparing two multivariate distributions based on adjacency. J R Stat Soc B. 2005;67(part 4):515-530. (Pubitemid 41351403)
50. Pham HH, Schrag D, O'Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007;356(11):1130-1139. (Pubitemid 46425597)
51. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575-584. (Pubitemid 39028925)
52. 2011 National Healthcare Quality and Disparities Reports. Agency for Healthcare Research and Quality website. www.ahrq.gov/research/findings/nhqrdr/ nhqrdr11/qrdr11.html. 2011. Accessed November 12, 2012.
53. Daniel SR, Armstrong K, Silber JH, et al. An algorithm for optimal tapered matching, with application to disparities in survival. J Comput Graph Stat. 2008;17(4):914-924.
54. Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120-4128.
55. Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol. 2009;27(21):3445-3451.
56. Ma AM, Barone J, Wallis AE, et al. Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg. 2008;196(4):500-504.
57. Owusu C, Buist DS, Field TS, et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008;26(4):549-555. (Pubitemid 351264347)
58. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-2502. (Pubitemid 43854964)